nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—ACHE—breast cancer	0.647	1	CbGaD
Gallamine Triethiodide—ACHE—Irinotecan—breast cancer	0.0788	1	CbGbCtD
Gallamine Triethiodide—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000114	0.000494	CcSEcCtD
Gallamine Triethiodide—Nausea—Melphalan—breast cancer	0.000114	0.000493	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Irinotecan—breast cancer	0.000114	0.000493	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Mitoxantrone—breast cancer	0.000114	0.000493	CcSEcCtD
Gallamine Triethiodide—Confusional state—Paclitaxel—breast cancer	0.000114	0.000492	CcSEcCtD
Gallamine Triethiodide—Pruritus—Thiotepa—breast cancer	0.000113	0.00049	CcSEcCtD
Gallamine Triethiodide—Pain—Fluorouracil—breast cancer	0.000113	0.00049	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Epirubicin—breast cancer	0.000112	0.000485	CcSEcCtD
Gallamine Triethiodide—Nausea—Goserelin—breast cancer	0.000111	0.000481	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Capecitabine—breast cancer	0.000111	0.00048	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Gemcitabine—breast cancer	0.000111	0.00048	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Doxorubicin—breast cancer	0.000111	0.000479	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Paclitaxel—breast cancer	0.00011	0.000477	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Paclitaxel—breast cancer	0.00011	0.000476	CcSEcCtD
Gallamine Triethiodide—Urticaria—Mitoxantrone—breast cancer	0.00011	0.000475	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Thiotepa—breast cancer	0.00011	0.000474	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Paclitaxel—breast cancer	0.00011	0.000474	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Mitoxantrone—breast cancer	0.000109	0.000473	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Irinotecan—breast cancer	0.000109	0.000473	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Irinotecan—breast cancer	0.000109	0.000473	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Mitoxantrone—breast cancer	0.000109	0.000473	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Fluorouracil—breast cancer	0.000109	0.000472	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Doxorubicin—breast cancer	0.000109	0.000469	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—breast cancer	0.000108	0.000468	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Epirubicin—breast cancer	0.000108	0.000465	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vinorelbine—breast cancer	0.000107	0.000461	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Gemcitabine—breast cancer	0.000107	0.00046	CcSEcCtD
Gallamine Triethiodide—Rash—Vinorelbine—breast cancer	0.000106	0.000457	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vinorelbine—breast cancer	0.000106	0.000457	CcSEcCtD
Gallamine Triethiodide—Urticaria—Fluorouracil—breast cancer	0.000105	0.000455	CcSEcCtD
Gallamine Triethiodide—Headache—Vinorelbine—breast cancer	0.000105	0.000454	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—breast cancer	0.000105	0.000453	CcSEcCtD
Gallamine Triethiodide—Anaemia—Capecitabine—breast cancer	0.000105	0.000453	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Fluorouracil—breast cancer	0.000105	0.000453	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Doxorubicin—breast cancer	0.000104	0.000449	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000103	0.000444	CcSEcCtD
Gallamine Triethiodide—Malaise—Capecitabine—breast cancer	0.000102	0.000442	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—breast cancer	0.000102	0.000442	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Mitoxantrone—breast cancer	0.000102	0.00044	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Irinotecan—breast cancer	0.000102	0.00044	CcSEcCtD
Gallamine Triethiodide—Vomiting—Thiotepa—breast cancer	0.000102	0.00044	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Capecitabine—breast cancer	0.000102	0.000439	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Paclitaxel—breast cancer	0.000101	0.000438	CcSEcCtD
Gallamine Triethiodide—Rash—Thiotepa—breast cancer	0.000101	0.000436	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Thiotepa—breast cancer	0.000101	0.000436	CcSEcCtD
Gallamine Triethiodide—Headache—Thiotepa—breast cancer	0.0001	0.000434	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—breast cancer	9.98e-05	0.000431	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—breast cancer	9.98e-05	0.000431	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Doxorubicin—breast cancer	9.97e-05	0.000431	CcSEcCtD
Gallamine Triethiodide—Nausea—Vinorelbine—breast cancer	9.96e-05	0.000431	CcSEcCtD
Gallamine Triethiodide—Asthenia—Mitoxantrone—breast cancer	9.93e-05	0.000429	CcSEcCtD
Gallamine Triethiodide—Asthenia—Irinotecan—breast cancer	9.93e-05	0.000429	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	9.91e-05	0.000428	CcSEcCtD
Gallamine Triethiodide—Cough—Capecitabine—breast cancer	9.9e-05	0.000428	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Fluorouracil—breast cancer	9.76e-05	0.000422	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Methotrexate—breast cancer	9.75e-05	0.000421	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Paclitaxel—breast cancer	9.74e-05	0.000421	CcSEcCtD
Gallamine Triethiodide—Fatigue—Paclitaxel—breast cancer	9.73e-05	0.00042	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Methotrexate—breast cancer	9.7e-05	0.000419	CcSEcCtD
Gallamine Triethiodide—Asthenia—Gemcitabine—breast cancer	9.67e-05	0.000418	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Capecitabine—breast cancer	9.66e-05	0.000417	CcSEcCtD
Gallamine Triethiodide—Chest pain—Capecitabine—breast cancer	9.66e-05	0.000417	CcSEcCtD
Gallamine Triethiodide—Pain—Paclitaxel—breast cancer	9.65e-05	0.000417	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—breast cancer	9.64e-05	0.000417	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	9.59e-05	0.000414	CcSEcCtD
Gallamine Triethiodide—Pruritus—Gemcitabine—breast cancer	9.53e-05	0.000412	CcSEcCtD
Gallamine Triethiodide—Nausea—Thiotepa—breast cancer	9.52e-05	0.000411	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Mitoxantrone—breast cancer	9.47e-05	0.000409	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Irinotecan—breast cancer	9.47e-05	0.000409	CcSEcCtD
Gallamine Triethiodide—Pruritus—Fluorouracil—breast cancer	9.37e-05	0.000405	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—breast cancer	9.36e-05	0.000405	CcSEcCtD
Gallamine Triethiodide—Confusional state—Capecitabine—breast cancer	9.34e-05	0.000403	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—breast cancer	9.33e-05	0.000403	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Paclitaxel—breast cancer	9.3e-05	0.000402	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—breast cancer	9.29e-05	0.000401	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Gemcitabine—breast cancer	9.22e-05	0.000398	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Epirubicin—breast cancer	9.13e-05	0.000394	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Epirubicin—breast cancer	9.1e-05	0.000393	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Epirubicin—breast cancer	9.08e-05	0.000392	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Methotrexate—breast cancer	9.07e-05	0.000392	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Fluorouracil—breast cancer	9.07e-05	0.000392	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Capecitabine—breast cancer	9.07e-05	0.000392	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Capecitabine—breast cancer	9.04e-05	0.00039	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Epirubicin—breast cancer	9.03e-05	0.00039	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Methotrexate—breast cancer	9e-05	0.000389	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Capecitabine—breast cancer	8.99e-05	0.000389	CcSEcCtD
Gallamine Triethiodide—Urticaria—Paclitaxel—breast cancer	8.96e-05	0.000387	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Paclitaxel—breast cancer	8.92e-05	0.000385	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Paclitaxel—breast cancer	8.92e-05	0.000385	CcSEcCtD
Gallamine Triethiodide—Vomiting—Mitoxantrone—breast cancer	8.8e-05	0.00038	CcSEcCtD
Gallamine Triethiodide—Vomiting—Irinotecan—breast cancer	8.8e-05	0.00038	CcSEcCtD
Gallamine Triethiodide—Rash—Mitoxantrone—breast cancer	8.72e-05	0.000377	CcSEcCtD
Gallamine Triethiodide—Rash—Irinotecan—breast cancer	8.72e-05	0.000377	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Mitoxantrone—breast cancer	8.71e-05	0.000377	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Irinotecan—breast cancer	8.71e-05	0.000377	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—breast cancer	8.71e-05	0.000376	CcSEcCtD
Gallamine Triethiodide—Headache—Mitoxantrone—breast cancer	8.67e-05	0.000374	CcSEcCtD
Gallamine Triethiodide—Headache—Irinotecan—breast cancer	8.67e-05	0.000374	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—breast cancer	8.59e-05	0.000371	CcSEcCtD
Gallamine Triethiodide—Vomiting—Gemcitabine—breast cancer	8.57e-05	0.00037	CcSEcCtD
Gallamine Triethiodide—Rash—Gemcitabine—breast cancer	8.5e-05	0.000367	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Gemcitabine—breast cancer	8.49e-05	0.000367	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Epirubicin—breast cancer	8.48e-05	0.000367	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Doxorubicin—breast cancer	8.44e-05	0.000365	CcSEcCtD
Gallamine Triethiodide—Headache—Gemcitabine—breast cancer	8.44e-05	0.000365	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Capecitabine—breast cancer	8.44e-05	0.000364	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Epirubicin—breast cancer	8.43e-05	0.000364	CcSEcCtD
Gallamine Triethiodide—Vomiting—Fluorouracil—breast cancer	8.42e-05	0.000364	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Doxorubicin—breast cancer	8.42e-05	0.000364	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Doxorubicin—breast cancer	8.4e-05	0.000363	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Doxorubicin—breast cancer	8.36e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Rash—Fluorouracil—breast cancer	8.35e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Fluorouracil—breast cancer	8.35e-05	0.000361	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Capecitabine—breast cancer	8.31e-05	0.000359	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Paclitaxel—breast cancer	8.31e-05	0.000359	CcSEcCtD
Gallamine Triethiodide—Headache—Fluorouracil—breast cancer	8.3e-05	0.000359	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Methotrexate—breast cancer	8.27e-05	0.000357	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—breast cancer	8.26e-05	0.000357	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—breast cancer	8.25e-05	0.000356	CcSEcCtD
Gallamine Triethiodide—Nausea—Mitoxantrone—breast cancer	8.22e-05	0.000355	CcSEcCtD
Gallamine Triethiodide—Nausea—Irinotecan—breast cancer	8.22e-05	0.000355	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—breast cancer	8.18e-05	0.000353	CcSEcCtD
Gallamine Triethiodide—Asthenia—Paclitaxel—breast cancer	8.1e-05	0.00035	CcSEcCtD
Gallamine Triethiodide—Nausea—Gemcitabine—breast cancer	8e-05	0.000346	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Capecitabine—breast cancer	7.99e-05	0.000345	CcSEcCtD
Gallamine Triethiodide—Fatigue—Capecitabine—breast cancer	7.98e-05	0.000345	CcSEcCtD
Gallamine Triethiodide—Pruritus—Paclitaxel—breast cancer	7.98e-05	0.000345	CcSEcCtD
Gallamine Triethiodide—Pain—Capecitabine—breast cancer	7.92e-05	0.000342	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—breast cancer	7.88e-05	0.000341	CcSEcCtD
Gallamine Triethiodide—Nausea—Fluorouracil—breast cancer	7.87e-05	0.00034	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Doxorubicin—breast cancer	7.85e-05	0.000339	CcSEcCtD
Gallamine Triethiodide—Anaemia—Methotrexate—breast cancer	7.81e-05	0.000337	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Doxorubicin—breast cancer	7.8e-05	0.000337	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Epirubicin—breast cancer	7.74e-05	0.000334	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Paclitaxel—breast cancer	7.72e-05	0.000334	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Capecitabine—breast cancer	7.63e-05	0.00033	CcSEcCtD
Gallamine Triethiodide—Malaise—Methotrexate—breast cancer	7.62e-05	0.000329	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—breast cancer	7.56e-05	0.000327	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—breast cancer	7.56e-05	0.000327	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Methotrexate—breast cancer	7.56e-05	0.000327	CcSEcCtD
Gallamine Triethiodide—Cough—Methotrexate—breast cancer	7.37e-05	0.000318	CcSEcCtD
Gallamine Triethiodide—Urticaria—Capecitabine—breast cancer	7.36e-05	0.000318	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Capecitabine—breast cancer	7.32e-05	0.000316	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Capecitabine—breast cancer	7.32e-05	0.000316	CcSEcCtD
Gallamine Triethiodide—Anaemia—Epirubicin—breast cancer	7.31e-05	0.000316	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Methotrexate—breast cancer	7.19e-05	0.000311	CcSEcCtD
Gallamine Triethiodide—Chest pain—Methotrexate—breast cancer	7.19e-05	0.000311	CcSEcCtD
Gallamine Triethiodide—Vomiting—Paclitaxel—breast cancer	7.17e-05	0.00031	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Doxorubicin—breast cancer	7.16e-05	0.000309	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	7.14e-05	0.000309	CcSEcCtD
Gallamine Triethiodide—Malaise—Epirubicin—breast cancer	7.13e-05	0.000308	CcSEcCtD
Gallamine Triethiodide—Rash—Paclitaxel—breast cancer	7.11e-05	0.000307	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Paclitaxel—breast cancer	7.11e-05	0.000307	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Epirubicin—breast cancer	7.07e-05	0.000306	CcSEcCtD
Gallamine Triethiodide—Headache—Paclitaxel—breast cancer	7.07e-05	0.000305	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—breast cancer	7.05e-05	0.000304	CcSEcCtD
Gallamine Triethiodide—Confusional state—Methotrexate—breast cancer	6.95e-05	0.0003	CcSEcCtD
Gallamine Triethiodide—Cough—Epirubicin—breast cancer	6.9e-05	0.000298	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—breast cancer	6.86e-05	0.000296	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Capecitabine—breast cancer	6.82e-05	0.000295	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—breast cancer	6.77e-05	0.000292	CcSEcCtD
Gallamine Triethiodide—Anaemia—Doxorubicin—breast cancer	6.76e-05	0.000292	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Methotrexate—breast cancer	6.75e-05	0.000292	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Epirubicin—breast cancer	6.73e-05	0.000291	CcSEcCtD
Gallamine Triethiodide—Chest pain—Epirubicin—breast cancer	6.73e-05	0.000291	CcSEcCtD
Gallamine Triethiodide—Nausea—Paclitaxel—breast cancer	6.7e-05	0.00029	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Methotrexate—breast cancer	6.7e-05	0.000289	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	6.68e-05	0.000289	CcSEcCtD
Gallamine Triethiodide—Asthenia—Capecitabine—breast cancer	6.64e-05	0.000287	CcSEcCtD
Gallamine Triethiodide—Malaise—Doxorubicin—breast cancer	6.59e-05	0.000285	CcSEcCtD
Gallamine Triethiodide—Pruritus—Capecitabine—breast cancer	6.55e-05	0.000283	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Doxorubicin—breast cancer	6.55e-05	0.000283	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—breast cancer	6.54e-05	0.000283	CcSEcCtD
Gallamine Triethiodide—Confusional state—Epirubicin—breast cancer	6.5e-05	0.000281	CcSEcCtD
Gallamine Triethiodide—Cough—Doxorubicin—breast cancer	6.38e-05	0.000276	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Capecitabine—breast cancer	6.34e-05	0.000274	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Epirubicin—breast cancer	6.32e-05	0.000273	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Epirubicin—breast cancer	6.3e-05	0.000272	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Methotrexate—breast cancer	6.28e-05	0.000271	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Epirubicin—breast cancer	6.27e-05	0.000271	CcSEcCtD
Gallamine Triethiodide—Chest pain—Doxorubicin—breast cancer	6.23e-05	0.000269	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Doxorubicin—breast cancer	6.23e-05	0.000269	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Methotrexate—breast cancer	6.19e-05	0.000267	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	6.18e-05	0.000267	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—breast cancer	6.08e-05	0.000263	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—breast cancer	6.03e-05	0.000261	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—breast cancer	6.02e-05	0.00026	CcSEcCtD
Gallamine Triethiodide—Confusional state—Doxorubicin—breast cancer	6.02e-05	0.00026	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—breast cancer	5.99e-05	0.000259	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Methotrexate—breast cancer	5.95e-05	0.000257	CcSEcCtD
Gallamine Triethiodide—Fatigue—Methotrexate—breast cancer	5.94e-05	0.000257	CcSEcCtD
Gallamine Triethiodide—Pain—Methotrexate—breast cancer	5.89e-05	0.000255	CcSEcCtD
Gallamine Triethiodide—Vomiting—Capecitabine—breast cancer	5.89e-05	0.000254	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Epirubicin—breast cancer	5.88e-05	0.000254	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Doxorubicin—breast cancer	5.84e-05	0.000252	CcSEcCtD
Gallamine Triethiodide—Rash—Capecitabine—breast cancer	5.84e-05	0.000252	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Capecitabine—breast cancer	5.83e-05	0.000252	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Doxorubicin—breast cancer	5.83e-05	0.000252	CcSEcCtD
Gallamine Triethiodide—Headache—Capecitabine—breast cancer	5.8e-05	0.000251	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Doxorubicin—breast cancer	5.8e-05	0.00025	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Epirubicin—breast cancer	5.79e-05	0.00025	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—breast cancer	5.68e-05	0.000245	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Methotrexate—breast cancer	5.68e-05	0.000245	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Epirubicin—breast cancer	5.57e-05	0.000241	CcSEcCtD
Gallamine Triethiodide—Fatigue—Epirubicin—breast cancer	5.56e-05	0.00024	CcSEcCtD
Gallamine Triethiodide—Pain—Epirubicin—breast cancer	5.52e-05	0.000238	CcSEcCtD
Gallamine Triethiodide—Nausea—Capecitabine—breast cancer	5.5e-05	0.000238	CcSEcCtD
Gallamine Triethiodide—Urticaria—Methotrexate—breast cancer	5.48e-05	0.000237	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Methotrexate—breast cancer	5.45e-05	0.000235	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Methotrexate—breast cancer	5.45e-05	0.000235	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Doxorubicin—breast cancer	5.44e-05	0.000235	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Doxorubicin—breast cancer	5.36e-05	0.000232	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Epirubicin—breast cancer	5.32e-05	0.00023	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Doxorubicin—breast cancer	5.15e-05	0.000223	CcSEcCtD
Gallamine Triethiodide—Fatigue—Doxorubicin—breast cancer	5.15e-05	0.000222	CcSEcCtD
Gallamine Triethiodide—Urticaria—Epirubicin—breast cancer	5.12e-05	0.000221	CcSEcCtD
Gallamine Triethiodide—Pain—Doxorubicin—breast cancer	5.1e-05	0.000221	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Epirubicin—breast cancer	5.1e-05	0.00022	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Epirubicin—breast cancer	5.1e-05	0.00022	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Methotrexate—breast cancer	5.08e-05	0.000219	CcSEcCtD
Gallamine Triethiodide—Asthenia—Methotrexate—breast cancer	4.95e-05	0.000214	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Doxorubicin—breast cancer	4.92e-05	0.000213	CcSEcCtD
Gallamine Triethiodide—Pruritus—Methotrexate—breast cancer	4.88e-05	0.000211	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Epirubicin—breast cancer	4.75e-05	0.000205	CcSEcCtD
Gallamine Triethiodide—Urticaria—Doxorubicin—breast cancer	4.74e-05	0.000205	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Doxorubicin—breast cancer	4.72e-05	0.000204	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Doxorubicin—breast cancer	4.72e-05	0.000204	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Methotrexate—breast cancer	4.72e-05	0.000204	CcSEcCtD
Gallamine Triethiodide—Asthenia—Epirubicin—breast cancer	4.63e-05	0.0002	CcSEcCtD
Gallamine Triethiodide—Pruritus—Epirubicin—breast cancer	4.56e-05	0.000197	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Epirubicin—breast cancer	4.41e-05	0.000191	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Doxorubicin—breast cancer	4.4e-05	0.00019	CcSEcCtD
Gallamine Triethiodide—Vomiting—Methotrexate—breast cancer	4.38e-05	0.000189	CcSEcCtD
Gallamine Triethiodide—Rash—Methotrexate—breast cancer	4.35e-05	0.000188	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Methotrexate—breast cancer	4.34e-05	0.000188	CcSEcCtD
Gallamine Triethiodide—Headache—Methotrexate—breast cancer	4.32e-05	0.000187	CcSEcCtD
Gallamine Triethiodide—Asthenia—Doxorubicin—breast cancer	4.28e-05	0.000185	CcSEcCtD
Gallamine Triethiodide—Pruritus—Doxorubicin—breast cancer	4.22e-05	0.000182	CcSEcCtD
Gallamine Triethiodide—Vomiting—Epirubicin—breast cancer	4.1e-05	0.000177	CcSEcCtD
Gallamine Triethiodide—Nausea—Methotrexate—breast cancer	4.09e-05	0.000177	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Doxorubicin—breast cancer	4.08e-05	0.000176	CcSEcCtD
Gallamine Triethiodide—Rash—Epirubicin—breast cancer	4.07e-05	0.000176	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Epirubicin—breast cancer	4.06e-05	0.000176	CcSEcCtD
Gallamine Triethiodide—Headache—Epirubicin—breast cancer	4.04e-05	0.000175	CcSEcCtD
Gallamine Triethiodide—Nausea—Epirubicin—breast cancer	3.83e-05	0.000166	CcSEcCtD
Gallamine Triethiodide—Vomiting—Doxorubicin—breast cancer	3.79e-05	0.000164	CcSEcCtD
Gallamine Triethiodide—Rash—Doxorubicin—breast cancer	3.76e-05	0.000163	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Doxorubicin—breast cancer	3.76e-05	0.000162	CcSEcCtD
Gallamine Triethiodide—Headache—Doxorubicin—breast cancer	3.74e-05	0.000162	CcSEcCtD
Gallamine Triethiodide—Nausea—Doxorubicin—breast cancer	3.55e-05	0.000153	CcSEcCtD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CNR2—breast cancer	2.54e-05	0.00059	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA3—breast cancer	2.48e-05	0.000577	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL8—breast cancer	2.47e-05	0.000575	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A2—breast cancer	2.46e-05	0.000573	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—breast cancer	2.46e-05	0.000572	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RSPO3—breast cancer	2.45e-05	0.00057	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.44e-05	0.000567	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—HRAS—breast cancer	2.43e-05	0.000565	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CPT1A—breast cancer	2.41e-05	0.000561	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTR—breast cancer	2.41e-05	0.000561	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCG2—breast cancer	2.41e-05	0.000561	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP1—breast cancer	2.41e-05	0.000561	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL2—breast cancer	2.4e-05	0.000559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR2—breast cancer	2.4e-05	0.000559	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—breast cancer	2.39e-05	0.000556	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WNT10B—breast cancer	2.38e-05	0.000555	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WWOX—breast cancer	2.38e-05	0.000555	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—WNT1—breast cancer	2.38e-05	0.000555	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PTHLH—breast cancer	2.37e-05	0.000552	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HPGDS—breast cancer	2.36e-05	0.00055	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HBA1—breast cancer	2.35e-05	0.000547	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LEP—breast cancer	2.33e-05	0.000543	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE2A—breast cancer	2.32e-05	0.000541	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL27—breast cancer	2.32e-05	0.000541	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—INHBB—breast cancer	2.32e-05	0.000541	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL3—breast cancer	2.32e-05	0.000541	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—EDNRB—breast cancer	2.3e-05	0.000535	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTT1—breast cancer	2.29e-05	0.000534	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—breast cancer	2.26e-05	0.000525	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.23e-05	0.000518	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BMPR2—breast cancer	2.22e-05	0.000516	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DLL4—breast cancer	2.22e-05	0.000516	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL2—breast cancer	2.18e-05	0.000507	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR2—breast cancer	2.18e-05	0.000507	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP17A1—breast cancer	2.17e-05	0.000505	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PTHLH—breast cancer	2.16e-05	0.000502	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS1—breast cancer	2.15e-05	0.0005	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ENO1—breast cancer	2.15e-05	0.0005	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.14e-05	0.000498	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDH5—breast cancer	2.13e-05	0.000495	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.11e-05	0.000492	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP2D6—breast cancer	2.11e-05	0.00049	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CALCA—breast cancer	2.09e-05	0.000486	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EDNRB—breast cancer	2.09e-05	0.000486	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SFRP2—breast cancer	2.08e-05	0.000485	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA2—breast cancer	2.07e-05	0.000481	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRLR—breast cancer	2.05e-05	0.000476	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL12—breast cancer	2.04e-05	0.000475	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR4—breast cancer	2.04e-05	0.000475	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—FASN—breast cancer	2.01e-05	0.000467	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—BCHE—breast cancer	2e-05	0.000465	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VCP—breast cancer	1.98e-05	0.00046	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GLI2—breast cancer	1.98e-05	0.00046	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC5A5—breast cancer	1.97e-05	0.000459	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	1.97e-05	0.000457	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEPR—breast cancer	1.94e-05	0.000452	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL6—breast cancer	1.93e-05	0.000448	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—IGF1—breast cancer	1.93e-05	0.000448	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NQO1—breast cancer	1.91e-05	0.000444	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SLC2A1—breast cancer	1.91e-05	0.000444	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CALCA—breast cancer	1.9e-05	0.000442	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.87e-05	0.000434	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—MMP2—breast cancer	1.87e-05	0.000434	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—HRAS—breast cancer	1.86e-05	0.000433	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP3A4—breast cancer	1.86e-05	0.000433	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR4—breast cancer	1.85e-05	0.000431	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL12—breast cancer	1.85e-05	0.000431	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.85e-05	0.00043	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR1—breast cancer	1.85e-05	0.00043	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1B1—breast cancer	1.83e-05	0.000425	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ARHGDIA—breast cancer	1.81e-05	0.000421	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HSP90AA1—breast cancer	1.79e-05	0.000417	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FST—breast cancer	1.76e-05	0.00041	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOA1—breast cancer	1.74e-05	0.000406	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HEY2—breast cancer	1.74e-05	0.000405	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RPS6KB2—breast cancer	1.72e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—STK11—breast cancer	1.72e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP19A1—breast cancer	1.72e-05	0.0004	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RGS2—breast cancer	1.7e-05	0.000395	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCL20—breast cancer	1.68e-05	0.000391	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR1—breast cancer	1.68e-05	0.00039	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ITPR1—breast cancer	1.66e-05	0.000385	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TLE3—breast cancer	1.63e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LPAR1—breast cancer	1.63e-05	0.000379	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.61e-05	0.000375	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HEY1—breast cancer	1.61e-05	0.000375	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—COMT—breast cancer	1.6e-05	0.000372	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTP1—breast cancer	1.59e-05	0.00037	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DLL1—breast cancer	1.58e-05	0.000368	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—HMOX1—breast cancer	1.57e-05	0.000365	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ITPR1—breast cancer	1.56e-05	0.000364	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIST1H2BK—breast cancer	1.55e-05	0.000361	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIST1H2BC—breast cancer	1.55e-05	0.000361	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CXCL8—breast cancer	1.55e-05	0.000361	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GRB7—breast cancer	1.54e-05	0.000358	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDE4D—breast cancer	1.54e-05	0.000358	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CSF2—breast cancer	1.53e-05	0.000356	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TAB2—breast cancer	1.51e-05	0.000351	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ABCB1—breast cancer	1.5e-05	0.00035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ITPR1—breast cancer	1.5e-05	0.00035	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CNR2—breast cancer	1.5e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL8—breast cancer	1.5e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MMP3—breast cancer	1.49e-05	0.000348	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TYMS—breast cancer	1.48e-05	0.000344	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—DKK1—breast cancer	1.46e-05	0.00034	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PLA2G4A—breast cancer	1.46e-05	0.00034	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GSTM1—breast cancer	1.46e-05	0.00034	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NCOR1—breast cancer	1.46e-05	0.00034	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFC—breast cancer	1.45e-05	0.000337	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—CTNNB1—breast cancer	1.43e-05	0.000333	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAG2—breast cancer	1.43e-05	0.000332	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—WNT1—breast cancer	1.41e-05	0.000328	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PLA2G4A—breast cancer	1.4e-05	0.000327	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPX1—breast cancer	1.4e-05	0.000326	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CSF2—breast cancer	1.39e-05	0.000323	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CYP1A1—breast cancer	1.38e-05	0.000322	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ERCC2—breast cancer	1.37e-05	0.00032	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH4—breast cancer	1.33e-05	0.000311	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—GZMB—breast cancer	1.33e-05	0.000309	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—MTHFR—breast cancer	1.29e-05	0.0003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL2—breast cancer	1.29e-05	0.0003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR2—breast cancer	1.29e-05	0.0003	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BMP2—breast cancer	1.27e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTHLH—breast cancer	1.27e-05	0.000296	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EDNRB—breast cancer	1.23e-05	0.000287	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PGR—breast cancer	1.22e-05	0.000284	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—THBS1—breast cancer	1.21e-05	0.000283	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CAV1—breast cancer	1.19e-05	0.000277	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FLT1—breast cancer	1.16e-05	0.00027	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF3—breast cancer	1.15e-05	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SQSTM1—breast cancer	1.15e-05	0.000269	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CG—breast cancer	1.15e-05	0.000267	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JAG1—breast cancer	1.14e-05	0.000265	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.14e-05	0.000265	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH3—breast cancer	1.13e-05	0.000264	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PARP1—breast cancer	1.13e-05	0.000264	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CALCA—breast cancer	1.12e-05	0.000261	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RPS6—breast cancer	1.11e-05	0.000258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF4—breast cancer	1.1e-05	0.000256	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR4—breast cancer	1.1e-05	0.000255	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL12—breast cancer	1.1e-05	0.000255	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CG—breast cancer	1.08e-05	0.000252	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PAK1—breast cancer	1.07e-05	0.00025	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TCF7L2—breast cancer	1.06e-05	0.000246	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT2—breast cancer	1.05e-05	0.000245	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	1.04e-05	0.000243	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	1.02e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH2—breast cancer	1.02e-05	0.000237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	1.01e-05	0.000235	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PRL—breast cancer	9.9e-06	0.00023	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR1—breast cancer	9.9e-06	0.00023	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADAM10—breast cancer	9.76e-06	0.000227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STK11—breast cancer	9.76e-06	0.000227	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLG—breast cancer	9.65e-06	0.000225	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT2—breast cancer	9.54e-06	0.000222	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CD—breast cancer	9.54e-06	0.000222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF10—breast cancer	9.49e-06	0.000221	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ALB—breast cancer	9.41e-06	0.000219	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	9.17e-06	0.000213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PDGFA—breast cancer	9.16e-06	0.000213	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFBR2—breast cancer	9.03e-06	0.00021	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—NOS3—breast cancer	9.01e-06	0.00021	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ITPR1—breast cancer	8.89e-06	0.000207	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT5A—breast cancer	8.83e-06	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP3—breast cancer	8.83e-06	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB4—breast cancer	8.83e-06	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	8.8e-06	0.000205	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SMAD4—breast cancer	8.55e-06	0.000199	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1R—breast cancer	8.5e-06	0.000198	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	8.46e-06	0.000197	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HES1—breast cancer	8.35e-06	0.000194	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CB—breast cancer	8.31e-06	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NCOR1—breast cancer	8.3e-06	0.000193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	8.3e-06	0.000193	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTGS2—breast cancer	8.24e-06	0.000192	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CSF2—breast cancer	8.21e-06	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGF1—breast cancer	8.21e-06	0.000191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAF1—breast cancer	8.19e-06	0.00019	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NRG1—breast cancer	8.15e-06	0.00019	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—H2AFX—breast cancer	8.09e-06	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—IL2—breast cancer	8.08e-06	0.000188	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—E2F1—breast cancer	8.03e-06	0.000187	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	7.99e-06	0.000186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SPP1—breast cancer	7.72e-06	0.00018	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL8—breast cancer	7.68e-06	0.000179	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB3—breast cancer	7.63e-06	0.000178	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR2—breast cancer	7.62e-06	0.000177	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL2—breast cancer	7.34e-06	0.000171	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TERT—breast cancer	7.31e-06	0.00017	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PTEN—breast cancer	7.18e-06	0.000167	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FGFR1—breast cancer	7.1e-06	0.000165	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HIF1A—breast cancer	6.99e-06	0.000163	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—LEP—breast cancer	6.83e-06	0.000159	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CAV1—breast cancer	6.77e-06	0.000157	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KDR—breast cancer	6.69e-06	0.000156	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ESR1—breast cancer	6.52e-06	0.000152	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—FN1—breast cancer	6.44e-06	0.00015	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NFKBIA—breast cancer	6.36e-06	0.000148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOTCH1—breast cancer	6.3e-06	0.000147	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KIT—breast cancer	6.16e-06	0.000143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CG—breast cancer	6.16e-06	0.000143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—APC—breast cancer	6.16e-06	0.000143	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGF—breast cancer	6.09e-06	0.000142	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—MAPK3—breast cancer	5.9e-06	0.000137	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—BRAF—breast cancer	5.79e-06	0.000135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IGF1—breast cancer	5.64e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT2—breast cancer	5.64e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—breast cancer	5.61e-06	0.000131	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CD—breast cancer	5.42e-06	0.000126	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	5.37e-06	0.000125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SERPINE1—breast cancer	5.36e-06	0.000125	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—KRAS—breast cancer	5.3e-06	0.000123	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—NOS3—breast cancer	5.12e-06	0.000119	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—PIK3CA—breast cancer	5.07e-06	0.000118	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	4.87e-06	0.000113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MDM2—breast cancer	4.85e-06	0.000113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAF1—breast cancer	4.84e-06	0.000113	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RELA—breast cancer	4.81e-06	0.000112	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ERBB2—breast cancer	4.78e-06	0.000111	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CB—breast cancer	4.72e-06	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MTOR—breast cancer	4.72e-06	0.00011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL8—breast cancer	4.54e-06	0.000106	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—HRAS—breast cancer	4.51e-06	0.000105	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1B—breast cancer	4.43e-06	0.000103	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AKT1—breast cancer	4.38e-06	0.000102	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CASP3—breast cancer	4.34e-06	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL2—breast cancer	4.34e-06	0.000101	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—IL6—breast cancer	4.31e-06	0.0001	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CCND1—breast cancer	4.23e-06	9.84e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—JUN—breast cancer	4.22e-06	9.81e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CTNNB1—breast cancer	4.19e-06	9.74e-05	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AKT1—breast cancer	4.14e-06	9.63e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MMP9—breast cancer	4.1e-06	9.55e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CDKN1A—breast cancer	4.09e-06	9.51e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PTEN—breast cancer	4.08e-06	9.49e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK8—breast cancer	3.99e-06	9.29e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AKT1—breast cancer	3.98e-06	9.26e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—SRC—breast cancer	3.78e-06	8.8e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—VEGFA—breast cancer	3.69e-06	8.57e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—STAT3—breast cancer	3.65e-06	8.49e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MAPK3—breast cancer	3.49e-06	8.11e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—MYC—breast cancer	3.39e-06	7.89e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TGFB1—breast cancer	3.38e-06	7.87e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—breast cancer	3.32e-06	7.72e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—KRAS—breast cancer	3.13e-06	7.29e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PIK3CA—breast cancer	2.88e-06	6.7e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—TP53—breast cancer	2.78e-06	6.48e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—HRAS—breast cancer	2.66e-06	6.2e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—IL6—breast cancer	2.55e-06	5.93e-05	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AKT1—breast cancer	2.35e-06	5.47e-05	CbGpPWpGaD
